Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.4500
+0.0100 (2.27%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Kairos Pharma Employees
As of December 31, 2025, Kairos Pharma had 4 total employees, including 1 full-time and 3 part-time employees. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,459,750
Market Cap
9.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 1 | 3 |
| Dec 31, 2024 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| NextCure | 40 |
| Bolt Biotherapeutics | 23 |
| BioRestorative Therapies | 14 |
| Aprea Therapeutics | 8 |
| Ernexa Therapeutics | 7 |
| Immuron | 7 |
| Intensity Therapeutics | 7 |
| Jupiter Neurosciences | 5 |
KAPA News
- 4 days ago - Kairos Pharma issues letter from CEO that recaps year, details plans for 2026 - TheFly
- 4 days ago - Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders - Business Wire
- 13 days ago - Kairos Pharma Proxy statement: Proxy filing - Filings
- 17 days ago - Kairos Pharma Proxy statement: Proxy filing - Filings
- 21 days ago - Kairos Pharma Transcript: 16th Annual LD Micro Invitational Conference - Transcripts
- 24 days ago - Kairos Pharma Slides: Investor presentation - Filings
- 25 days ago - Kairos Pharma Receives GHP Magazine's Healthcare & Pharmaceutical Award - Business Wire
- 26 days ago - Kairos Pharma Quarterly report: Q1 2026 - Filings